烟酰胺单核苷酸增强靶向 MSLN 的 CAR-NK 细胞治疗在卵巢癌中的抗肿瘤疗效
Nicotinamide mononucleotide potentiates the anti-tumor efficacy of CAR-NK cell therapy targeting MSLN in ovarian cancer.
78.4分
★★★★☆
站内排序·非疗效
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
FRONTIER PAPERS
前沿论文 12
用于乳腺癌治疗的可注射水凝胶：从肿瘤微环境响应性与主动靶向药物递送到免疫治疗与诊疗一体化
Injectable Hydrogels for Breast Cancer Therapy: From Tumor Microenvironment-Responsive and Actively Targeted Drug Delivery to Immunotherapy and Theran
78.0分
★★★★☆
站内排序·非疗效
克服卵巢癌治疗耐药：从分子机制到新兴治疗策略
Overcoming Therapy Resistance in Ovarian Cancer: From Molecular Mechanisms to Emerging Therapeutic Strategies.
62.8分
★★★☆☆
站内排序·非疗效
人源化 ROBO1 CAR 整合至 NK 细胞 PD-1 位点对非小细胞肺癌产生协同杀伤肿瘤效应
Integration of humanized ROBO1 CAR in PD-1 locus in natural killer cells delivers synergistic tumor-killing effect against non-small cell lung cancer.
55.5分
★★★☆☆
站内排序·非疗效
ROBO1 CAR-NK92 细胞中 Cbl-b 敲除增强其抗肿瘤疗效
Ablation of Cbl-b in ROBO1 CAR-NK92 Cells Enhances Their Antitumor Efficacy.
54.9分
★★★☆☆
站内排序·非疗效
CRISPR 敲入嵌合抗原受体至 GAPDH 3'UTR 位点生成强效 B7H3 特异性 NK-92MI 细胞
CRISPR knock-in of a chimeric antigen receptor into GAPDH 3'UTR locus generates potent B7H3-specific NK-92MI cells.
50.3分
★★★☆☆
站内排序·非疗效
CAR-NK 细胞作为 T 细胞相关疾病体外疗法的潜在应用
Potential Application of CAR-NK Cells as an Ex Vivo Therapy for T-cell-related Diseases.
48.9分
★★★☆☆
站内排序·非疗效
肿瘤免疫治疗中新兴的固有免疫细胞：前景与挑战
Emerging Innate Immune Cells in Cancer Immunotherapy: Promises and Challenges.
48.0分
★★★☆☆
站内排序·非疗效
工程化 NK 细胞抗肿瘤及其潜在的其他应用
Engineered NK Cells Against Cancer and Their Potential Applications Beyond.
46.9分
★★★☆☆
站内排序·非疗效
工程化细胞作为胶质母细胞瘤治疗药物
Engineered cells as glioblastoma therapeutics.
46.9分
★★★☆☆
站内排序·非疗效